Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis
Schiele MA, Reif A, Lin J, Alpers GW, Andersson E, Andersson G, Arolt V, Bergström J, Carlbring P, Eley TC, Esquivel G, et al. (2021)
European Neuropsychopharmacology 44: 105-120.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Schiele, Miriam A.;
Reif, Andreas;
Lin, Jiaxi;
Alpers, Georg W.;
Andersson, Evelyn;
Andersson, Gerhard;
Arolt, Volker;
Bergström, Jan;
Carlbring, Per;
Eley, Thalia C.;
Esquivel, Gabriel;
Furmark, Tomas
Alle
Alle
Erscheinungsjahr
2021
Zeitschriftentitel
European Neuropsychopharmacology
Band
44
Seite(n)
105-120
ISSN
0924977X
Page URI
https://pub.uni-bielefeld.de/record/2985475
Zitieren
Schiele MA, Reif A, Lin J, et al. Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis. European Neuropsychopharmacology. 2021;44:105-120.
Schiele, M. A., Reif, A., Lin, J., Alpers, G. W., Andersson, E., Andersson, G., Arolt, V., et al. (2021). Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis. European Neuropsychopharmacology, 44, 105-120. https://doi.org/10.1016/j.euroneuro.2021.01.004
Schiele, Miriam A., Reif, Andreas, Lin, Jiaxi, Alpers, Georg W., Andersson, Evelyn, Andersson, Gerhard, Arolt, Volker, et al. 2021. “Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis”. European Neuropsychopharmacology 44: 105-120.
Schiele, M. A., Reif, A., Lin, J., Alpers, G. W., Andersson, E., Andersson, G., Arolt, V., Bergström, J., Carlbring, P., Eley, T. C., et al. (2021). Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis. European Neuropsychopharmacology 44, 105-120.
Schiele, M.A., et al., 2021. Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis. European Neuropsychopharmacology, 44, p 105-120.
M.A. Schiele, et al., “Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis”, European Neuropsychopharmacology, vol. 44, 2021, pp. 105-120.
Schiele, M.A., Reif, A., Lin, J., Alpers, G.W., Andersson, E., Andersson, G., Arolt, V., Bergström, J., Carlbring, P., Eley, T.C., Esquivel, G., Furmark, T., Gerlach, A.L., Hamm, A., Helbig-Lang, S., Hudson, J.L., Lang, T., Lester, K.J., Lindefors, N., Lonsdorf, T., Pauli, P., Richter, J., Rief, W., Roberts, S., Rück, C., Schruers, K.R.J., Thiel, C., Wittchen, H.-U., Domschke, K., Weber, H., Lueken, U.: Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis. European Neuropsychopharmacology. 44, 105-120 (2021).
Schiele, Miriam A., Reif, Andreas, Lin, Jiaxi, Alpers, Georg W., Andersson, Evelyn, Andersson, Gerhard, Arolt, Volker, Bergström, Jan, Carlbring, Per, Eley, Thalia C., Esquivel, Gabriel, Furmark, Tomas, Gerlach, Alexander L., Hamm, Alfons, Helbig-Lang, Sylvia, Hudson, Jennifer L., Lang, Thomas, Lester, Kathryn J., Lindefors, Nils, Lonsdorf, Tina, Pauli, Paul, Richter, Jan, Rief, Winfried, Roberts, Susanna, Rück, Christian, Schruers, Koen R.J., Thiel, Christiane, Wittchen, Hans-Ulrich, Domschke, Katharina, Weber, Heike, and Lueken, Ulrike. “Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis”. European Neuropsychopharmacology 44 (2021): 105-120.